Rasagiline Sensitive Dopamine D2 Receptor Gene Variants: A Step Forward Toward More Personalized Antiparkinsonian Therapy.
- Resource Type
- Article
- Source
Movement Disorders Clinical Practice . Mar/Apr2017, Vol. 4 Issue 2, p181-182. 2p.- Subject
- *
DOPAMINE receptors
*ANTIPARKINSONIAN agents
*GENETIC polymorphisms
*GENE expression
*DRUG development
*THERAPEUTICS - Language
- ISSN
- 2330-1619